40
Participants
Start Date
June 21, 2024
Primary Completion Date
July 15, 2024
Study Completion Date
July 15, 2024
Senaparib capsules(20mg)
Single oral dose of Senaparib administered under fasting condition, 1\*20mg capsules in first intervention period and then 2\*10mg capsules in second intervention period (after washout period: at least 5 days)
Senaparib capsules(10mg)
Single oral dose of Senaparib administered under fasting condition, 2\*10mg capsules in first intervention period and then 1\*20mg capsules in second intervention period (after washout period: at least 5 days)
Wuhan Jinyintan Hospital (Wuhan Infectious Disease Hospital), Wuhan
Lead Sponsor
Impact Therapeutics, Inc.
INDUSTRY